Fresh news on health and wellness in Grenada

Provided by AGP

Health Herald Grenada
Got News to Share?
Got News to Share? Explore more publications!

Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 4, 2026

CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
May. 4, 2026

CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition

Indeterminate GlobeNewswire
Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer
May. 4, 2026

Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer

Indeterminate GlobeNewswire
Curated Digital Health Works; Now There’s a Claims Study to Prove It
May. 4, 2026

Curated Digital Health Works; Now There’s a Claims Study to Prove It

Indeterminate GlobeNewswire
BioMogging Brings Research-Backed Rigour to Looksmaxxing as the Discipline Goes Mainstream
May. 4, 2026

BioMogging Brings Research-Backed Rigour to Looksmaxxing as the Discipline Goes Mainstream

Indeterminate GlobeNewswire
Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
May. 4, 2026

Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

Indeterminate GlobeNewswire
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
May. 4, 2026

Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company

Indeterminate GlobeNewswire
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic
May. 4, 2026

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic

Indeterminate GlobeNewswire
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
May. 4, 2026

Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform

Indeterminate GlobeNewswire
Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews
May. 4, 2026

Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews

Indeterminate GlobeNewswire
Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables
May. 4, 2026

Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces Date of First Quarter Financial Results
May. 4, 2026

Abeona Therapeutics® Announces Date of First Quarter Financial Results

Indeterminate GlobeNewswire
Sienna Continues Platform Growth
May. 4, 2026

Sienna Continues Platform Growth

Indeterminate GlobeNewswire
Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs
May. 4, 2026

Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs

Indeterminate GlobeNewswire
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
May. 4, 2026

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

Indeterminate GlobeNewswire
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
May. 4, 2026

Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET

Indeterminate GlobeNewswire
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
May. 4, 2026

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
May. 4, 2026

NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

Indeterminate GlobeNewswire
Serefin Health Launches MyCareSteps Program to Support Care Coordination Across Grey Bruce
May. 4, 2026

Serefin Health Launches MyCareSteps Program to Support Care Coordination Across Grey Bruce

Indeterminate GlobeNewswire
Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
May. 4, 2026

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

Indeterminate GlobeNewswire
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
May. 4, 2026

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Health Herald Grenada

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.